Prevention news, opinions and education

heartwire News

  • Alert FDA Okays Rivaroxaban Plus Aspirin for Chronic CAD, PAD The rivaroxaban/aspirin combination is for the prevention of thrombotic events in adults with coronary artery disease or symptomatic peripheral artery disease at high risk for ischemic events.
  • Five Major Changes in Canadian Guideline for Primary Care of Heart Disease The 2018 update of the Canadian Cardiovascular Harmonized National Guidelines Endeavor (C-CHANGE) guideline for the primary-care prevention and management of cardiovascular disease features 77 recommendations, including 52 that are newly added or updated and five areas that represent major changes.
  • Statins Show Little Evidence of Benefit in Non-CVD Conditions Despite growing interest in the use of statins for conditions unrelated to the heart, a rigorous analysis finds no strong support for their benefit beyond cardiovascular protection.
  • Intermittent Fasting Can Reverse Type 2 Diabetes in Some Cases Medically supervised intermittent fasting eliminated the need for insulin and reduced HbA1c and weight in three patients with type 2 diabetes; two were able to discontinue all diabetes medications.